According to the ACS, healthy men with a low or average risk of developing prostate cancer should talk to their doctor about screening at the age of 50. With PSA testing for prostate cancer screening are worth the harms associated with screening and subsequent unnecessary treatment. Prostate biopsies are used to diagnose prostate cancer but are not done on asymptomatic men and therefore are not used for screening.
The prostate-specific antigen test was approved in 1994 as a screening for prostate cancer in men who have no signs of the disease. There is clear evidence that screening with a prostate-specific antigen (PSA) test can reduce the number of deaths from prostate cancer. The standard screen test or early detection tests for prostate cancer are the Digital Rectal Exam, DRE, combined with the PSA Test. In addition to the introduction of the free PSA and cPSA tests, there have been efforts to increase the usefulness of the total PSA as a screening tool.
When a man has prostate cancer, his PSA levels tend to increase which is why a PSA test is often used by physicians to screen for prostate cancer. PSA testing does remain, however, an important tool in staging and monitoring prostate cancer once it has been diagnosed and helping assess response to treatment. The ultimate utility of the serum prostate specific antigen (PSA) assay as a screening test for reducing prostate cancer mortality has been an area of intense controversy since its introduction.
What is being tested? The PSA (prostate specific antigen) blood test can help detect or monitor prostate That is because the PSA test is not very accurate for screening men without symptoms. However, prostate cancer is often so slow growing that it would not cause a man any problems during the course of his life. Wie wichtig ist der Prostata-Wert, auch PSA Wert genannt? Wie aggressiv und gefährlich ist die Krankheit, auch im Betracht auf Alter?.
Doctors use the digital rectal exam (DRE) as a relatively simple test to check the the prostate is an internal organ, your doctor cannot look at it directly. When the complexed PSA (cPSA) test is used as a screening tool, increased levels may indicate an increased risk of prostate cancer, while lower levels indicate a decreased risk. Range does not substantially increase the number of biopsies needed to detect clinically significant prostate cancer compared to the 4 to 10 ng.